The Structural Genomics Consortium (SGC) Frankfurt is a new site of the SGC embedded in the
internationally renowned Buchmann Institute for Molecular Life Sciences, Goethe University Frankfurt.
SGC is a not-for-profit, public-private partnership encompassing 8 pharmaceutical companies that
conducts re-competitive research to facilitate the discovery of new medicines. Based at several
additional international universities (Oxford, Toronto, Chapel Hill, Campinas) the SGC's work contributes
to new hypotheses in understanding and treating human disease, and the subsequent identification of
new targets for drug discovery. The BMLS is integrated into several collaborative networks and contains
state-of-the-art technology platforms including EM, NMR and microscopy.
We are looking for outstanding candidates with experience in biochemistry and cell biology, who want to be part of our thriving scientific environment and play a significant role in extending our portfolio of autophagy assays within the SGC Frankfurt. The position will be housed in the Autophagy Probes Team (Dr. Stolz), which is focused on the development of different kinds of cell-based and biochemical screening assays for compounds targeting the autophagy pathway. Your role will be to become an expert in autophagy biology and compound screening techniques, and to use this expertise to advice and collaborate within and outside the department. You should be pro-active, creative, and curious about autophagy in regards to new findings and techniques. Being a great team player and collaborator is a must. Furthermore, you should fit within the following profile:
• Completed university degree in biochemistry/cell biology/chemistry or an equivalent field.
• Completed doctoral thesis (or postdoctoral work).
• Track record in successfully driving collaborations to publication.
• Expertise in structural biochemistry and microscopy is desirable
We offer a vibrant and collaborative environment performing cutting-edge research that brings together expertise in various biological and technological areas. An opportunity to take advantage of the technologies available, to become an expert on a wide range of screening assays, and to get in contact with our over 250 worldwide collaborators in academia and industry.
| Download |